Garth Cruickshank
Overview
Explore the profile of Garth Cruickshank including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capo M, Vitali S, Athanasiou G, Cusimano N, Garcia D, Cruickshank G, et al.
Neuroimage
. 2025 Feb;
308:121064.
PMID: 39892529
In this study, we present a comprehensive pipeline to train and compare a broad spectrum of machine learning and deep learning brain clocks, integrating diverse preprocessing strategies and correction terms....
2.
McConville C, Lastakchi S, Al Amri A, Ngoga D, Fayeye O, Cruickshank G
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272866
Glioblastomas are impossible to completely resect and almost always recur at the borders of the resection margin. There is no established chemotherapy regimen available to patients who recur, while systemic...
3.
Rees J, Cooper P, Cruickshank G, Jenkins N
Pract Neurol
. 2022 May;
PMID: 35580907
Driving is an integral part of adult life and losing a driving licence is potentially a major problem. Many neurological conditions may impact on driving, either by increasing the risk...
4.
Vargas-Caballero M, Warming H, Walker R, Holmes C, Cruickshank G, Patel B
Front Hum Neurosci
. 2022 May;
16:866434.
PMID: 35572001
Cognitive dysfunction in Alzheimer's disease (AD) is caused by disturbances in neuronal circuits of the brain underpinned by synapse loss, neuronal dysfunction and neuronal death. Amyloid beta and tau protein...
5.
Gawley M, Almond L, Daniel S, Lastakchi S, Kaur S, Detta A, et al.
J Control Release
. 2020 May;
324:1-16.
PMID: 32407745
Glioblastoma multiforme (GBM) is impossible to fully remove surgically and almost always recurs at the borders of the resection cavity, while systemic delivery of therapeutic drug levels to the brain...
6.
Hanna C, Kurian K, Williams K, Watts C, Jackson A, Carruthers R, et al.
Neuro Oncol
. 2020 Apr;
22(12):1840-1850.
PMID: 32347934
Background: The poly(ADP-ribose) polymerase (PARP) inhibitor olaparib potentiated radiation and temozolomide (TMZ) chemotherapy in preclinical glioblastoma models but brain penetration was poor. Clinically, PARP inhibitors exacerbate the hematological side effects...
7.
Eales K, Wilkinson E, Cruickshank G, Tucker J, Tennant D
Sci Rep
. 2018 Sep;
8(1):14358.
PMID: 30254296
Gliomas are highly malignant brain tumours characterised by extensive areas of poor perfusion which subsequently leads to hypoxia and reduced survival. Therapies that address the hypoxic microenvironment are likely to...
8.
Bates A, Gonzalez-Viana E, Cruickshank G, Roques T
BMJ
. 2018 Jul;
362:k2924.
PMID: 30018066
No abstract available.
9.
Hamilton P, Cruickshank G
J Surg Case Rep
. 2018 Jun;
2018(6):rjy134.
PMID: 29942482
CHIKV is a relatively new virus and we are still learning about the illness. Very little is known about CNS its involvement and even less about its delayed or long-term...
10.
Bennett S, Cruickshank G, Lindenmeyer A, Morris S
BMJ Open
. 2016 Nov;
6(11):e011616.
PMID: 27852703
Objectives: Headaches and facial pain have been identified as the most prevalent form of pain among patients with glioblastoma multiforme, the most common malignant primary brain tumour. Despite this, minimal...